Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 2,637 | 42,051 | 2,160 | 893 | 1,349 |
| Gross Profit | 2,637 | 42,051 | 2,160 | 893 | 1,349 |
| Operating Expenses | 7,963 | 7,156 | 7,287 | 6,350 | 6,050 |
| Operating Income | -5,326 | 34,895 | -5,127 | -5,457 | -4,701 |
| Interest Expense | 4 | 5 | 4 | 5 | 8 |
| Other Income | 240 | 41 | -72 | 92 | 266 |
| Pre-tax Income | -5,090 | 34,931 | -5,203 | -5,370 | -4,443 |
| Income Tax | -48 | -15,122 | N/A | N/A | N/A |
| Net Income Continuous | -5,042 | 50,053 | -5,203 | -5,370 | -4,443 |
| Net Income | $-5,042 | $50,053 | $-5,203 | $-5,370 | $-4,443 |
| EPS Basic Total Ops | -0.27 | 2.70 | -0.28 | -0.30 | -0.25 |
| EPS Basic Continuous Ops | -0.27 | 2.70 | -0.28 | -0.30 | -0.25 |
| EPS Diluted Total Ops | -0.27 | 2.61 | -0.28 | -0.30 | -0.25 |
| EPS Diluted Continuous Ops | -0.27 | 2.61 | -0.28 | -0.30 | -0.25 |
| EBITDA(a) | $-4,732 | $35,417 | $-4,481 | $-4,747 | $-4,063 |